Cellular immune responses to beta casein: elevated in but not specific for individuals with Type I diabetes mellitus

T M Ellis1, E Ottendorfer, E Jodoin

  • 1Department of Pathology, University of Florida College of Medicine, Gainesville 32610, USA.

Diabetologia
|July 14, 1998
PubMed

Insights

Cellular immune responses to cows' milk protein beta casein are elevated in new Type I diabetes mellitus patients. However, the role of this immune response in Type I diabetes pathogenesis remains unclear.

Area of Science:

  • Immunology
  • Endocrinology
  • Gastroenterology

Background:

  • Elevated cellular immune responses to cows' milk protein beta casein are observed in Type I diabetes mellitus.
  • This suggests a potential link between cows' milk consumption and Type I diabetes development.

Purpose of the Study:

  • To investigate cellular immune reactivities to beta casein in Type I diabetic patients, their relatives, and healthy controls.
  • To clarify the role of anti-beta casein immunity in the pathogenesis of Type I diabetes mellitus.

Main Methods:

  • Peripheral blood mononuclear cells were stimulated in vitro with beta casein preparations, control antigens, and a mitogen.
  • Cellular proliferation was measured in newly-diagnosed Type I diabetic subjects, autoantibody-negative relatives, and healthy controls.

Main Results:

  • Significantly higher cellular proliferation against beta casein was observed in Type I diabetic subjects compared to controls at high antigen concentrations.
  • Immune reactivities to beta casein were nearly identical between Type I diabetic probands and their autoantibody-negative relatives.
  • Cellular immune reactivities to other antigens were similar across all subject groups.

Conclusions:

  • Findings suggest individuals prone to autoimmunity may have impaired tolerance to dietary antigens.
  • The study highlights the need for matched subject populations in immune response analyses.
  • The specific role of anti-beta casein immunity in Type I diabetes pathogenesis requires further investigation.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...